iifl-logo

Pfizer Ltd Historical Data

4,949.8
(10.78%)
May 20, 2025|03:31:12 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Pfizer Ltd Historical Data

20/04/2025calendar-icon
20/05/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

21-Apr-2025

4,165

4,1994,1254,191.45,3968,89,18,65710,223

22-Apr-2025

4,200

4,269.34,163.24,254.54,7329,31,90,423.910,755

23-Apr-2025

4,267.8

4,2684,179.64,243.54,7306,72,51,333.18,184

24-Apr-2025

4,252

4,3474,233.74,275.97,30810,49,61,840.510,553

25-Apr-2025

4,288

4,3654,1774,248.96,87811,95,49,034.815,724

28-Apr-2025

4,250

4,335.34,202.14,274.16,4059,51,74,005.39,173

29-Apr-2025

4,295.5

4,297.84,2114,268.46,5505,93,19,202.56,904

30-Apr-2025

4,250

4,3384,227.24,292.85,9158,83,38,541.98,636

02-May-2025

4,310.5

4,3404,2504,297.24,9796,17,67,858.88,368

05-May-2025

4,314.9

4,325.94,2524,260.14,5604,77,18,291.86,420

06-May-2025

4,250

4,3114,222.64,243.67,2726,96,96,368.88,104

07-May-2025

4,200

4,3004,170.84,275.65,1827,57,99,060.68,548

08-May-2025

4,271

4,323.24,1884,2636,9026,03,29,017.88,023

09-May-2025

4,100.1

4,258.64,100.14,249.92,7115,83,36,894.87,590

12-May-2025

4,212

4,338.74,2124,249.44,4436,41,04,467.58,063

13-May-2025

4,269.3

4,3354,269.14,3245,5717,57,10,063.48,606

14-May-2025

4,338

4,412.74,302.24,4055,8399,23,49,131.311,647

15-May-2025

4,405

4,4904,3884,459.27,0398,06,91,873.510,225

16-May-2025

4,465.1

4,476.74,4004,413.23,3004,74,69,809.96,896

19-May-2025

4,448

4,4884,4054,4683,9406,69,63,372.56,786

Pfizer: Related NEWS

Pfizer Partners with Mylan to Boost Ativan and Pacitane Sales in India
23 Feb 2025|11:51 PM

Ativan is a common medication used predominantly for anxiety disorders, whereas Pacitane is used for Parkinson’s disease and other neurological conditions.

Read More
Pfizer Ties Up with Mylan to Boost Ativan and Pacitane Sales in India
21 Feb 2025|05:31 PM

The agreement, which is discussed up to April and approved by Pfizer's Board of Directors, will be for five years, with discussions ending on 21 February 2025.

Read More
Pfizer India Q3 Profit Slips 2% YoY
31 Jan 2025|11:34 PM

Revenue from operations decline marginally by 0.4% YoY at ₹538 crore, as against ₹540 crore in Q3 FY24

Read More
Pfizer reports 61% YoY profit surge in Q1 2024
30 Jul 2024|09:44 AM

At the operating level, EBITDA increased by 60.2%, reaching ₹177.5 Crore in the first quarter of this fiscal year, compared to ₹110.8 Crore in the same quarter last year.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.